ANTIOXIDANT STATUS IN AN INVITRO MODEL FOR HYPERGLYCEMIC LENS CATARACT FORMATION - EFFECT OF ALDOSE REDUCTASE INHIBITOR STATIL

被引：21

作者：

HOTHERSALL, JS ^{[1
]}

TAYLAUR, CE ^{[1
]}

MCLEAN, P ^{[1
]}

机构：

[1] MIDDLESEX SCH MED, LONDON W1P 6DB, ENGLAND

来源：

BIOCHEMICAL MEDICINE AND METABOLIC BIOLOGY | 1988年 / 40卷 / 02期

关键词：

D O I：

10.1016/0885-4505(88)90111-9

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

引用

页码：109 / 117

页数：9

共 33 条

[1]

Akerboom T P, 1981, Methods Enzymol, V77, P373

[2]

AUGUSTEYN RC, 1981, MECHANISMS CATARACT, P71

[3]

Bergmeyer H. V., 1962, METHODS ENZYMATIC AN

[4]

BHUYAN KC, 1981, IRCS MED SCI-BIOCHEM, V9, P126

[5] THE BIOCHEMISTRY OF THE COMPLICATIONS OF DIABETES-MELLITUS [J].

BROWNLEE, M ;

CERAMI, A .

CHENG, HM ;

GONZALEZ, RG .

METABOLISM-CLINICAL AND EXPERIMENTAL, 1986, 35 (04) :10-14

[7]

CREIGHTON MO, 1979, INVEST OPHTHALMOL S, V18, P212

[8]

DAISLEY KW, 1955, BIOCHEM J, V60, pX1

[9]

FLOHE L, 1974, GLUTATHIONE

[10]

FUKUI H, 1981, ABSTR INV OPTH VIS S, V20, P128